News

September 20, 2026 The seventh episode of the second season of From Care to Cure, a podcast from the Massachusetts General Hospital Frontotemporal Disorders Unit, is available today. In season [...]

July 28, 2026 The sixth episode of the second season of From Care to Cure, a podcast from the Massachusetts General Hospital Frontotemporal Disorders Unit, is available today. In season two, [...]

July 17, 2026 (London, England) Our Speech Language Pathology team attended and presented research at the inaugural International Conference on Primary Progressive Aphasia (ICPPA).  This [...]

July 16, 2026 (London, England) Our team presented a variety of new research findings at this conference, the largest forum in the world for the dementia research community. Our team’s [...]

July 12-16, 2026 (London, England) A large group of faculty and staff will represent the MGH FTD Unit in presenting the latest of our exciting research progress at the Alzheimer’s [...]

April 30, 2026 We are pleased to share that Axsome Therapeutics’ Auvelity has been granted FDA approval for the treatment of agitation associated with Alzheimer’s dementia. As the first [...]

June 20, 2026 The fifth episode of the second season of From Care to Cure, a podcast from the Massachusetts General Hospital Frontotemporal Disorders Unit, is available today. In season two, [...]

June 17, 2026 Providence, RI Katie Brandt, the MGH FTD Unit’s Director of Caregiver Support Services and Public Relations, was a featured speaker at the Alzheimer’s Foundation of [...]

May 27-30, 2026 In its 29th year, Brad Dickerson, MD, Director of the MGH FTD Unit, had the honor of co-directing the annual Harvard Medical School’s Dementia: A Comprehensive Update [...]

May 20, 2026 The fourth episode of the second season of From Care to Cure, a podcast from the Massachusetts General Hospital Frontotemporal Disorders Unit, is available today. In season two, [...]